Literature DB >> 23872679

Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1.

Nicole A de Weerd1, Julian P Vivian, Thao K Nguyen, Niamh E Mangan, Jodee A Gould, Susie-Jane Braniff, Leyla Zaker-Tabrizi, Ka Yee Fung, Samuel C Forster, Travis Beddoe, Hugh H Reid, Jamie Rossjohn, Paul J Hertzog.   

Abstract

Type I interferons are important in regulating immune responses to pathogens and tumors. All interferons are considered to signal via the heterodimeric IFNAR1-IFNAR2 complex, yet some subtypes such as interferon-β (IFN-β) can exhibit distinct functional properties, although the molecular basis of this is unclear. Here we demonstrate IFN-β can uniquely and specifically ligate to IFNAR1 in an IFNAR2-independent manner, and we provide the structural basis of the IFNAR1-IFN-β interaction. The IFNAR1-IFN-β complex transduced signals that modulated expression of a distinct set of genes independently of Jak-STAT pathways. Lipopolysaccharide-induced sepsis was ameliorated in Ifnar1(-/-) mice but not Ifnar2(-/-) mice, suggesting that IFNAR1-IFN-β signaling is pathologically relevant. Thus, we provide a molecular basis for understanding specific functions of IFN-β.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23872679     DOI: 10.1038/ni.2667

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  51 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 2.  The interferons: 50 years after their discovery, there is much more to learn.

Authors:  Sidney Pestka
Journal:  J Biol Chem       Date:  2007-05-14       Impact factor: 5.157

3.  The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities.

Authors:  Eyal Kalie; Diego A Jaitin; Yulia Podoplelova; Jacob Piehler; Gideon Schreiber
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

4.  Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock.

Authors:  Marina Karaghiosoff; Ralf Steinborn; Pavel Kovarik; Gernot Kriegshäuser; Manuela Baccarini; Birgit Donabauer; Ursula Reichart; Thomas Kolbe; Christian Bogdan; Tomas Leanderson; David Levy; Thomas Decker; Mathias Müller
Journal:  Nat Immunol       Date:  2003-04-07       Impact factor: 25.606

5.  IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.

Authors:  Claire J Greenhill; Stefan Rose-John; Rami Lissilaa; Walter Ferlin; Matthias Ernst; Paul J Hertzog; Ashley Mansell; Brendan J Jenkins
Journal:  J Immunol       Date:  2010-12-10       Impact factor: 5.422

6.  Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.

Authors:  Peter Lamken; Martynas Gavutis; Imke Peters; José Van der Heyden; Gilles Uzé; Jacob Piehler
Journal:  J Mol Biol       Date:  2005-07-15       Impact factor: 5.469

7.  Generation and characterization of recombinant unmodified and phosphorylatable murine IFN-alpha1 in the methylotropic yeast Pichia pastoris.

Authors:  S Trajanovska; C M Owczarek; P G Stanton; P J Hertzog
Journal:  J Interferon Cytokine Res       Date:  2003-07       Impact factor: 2.607

8.  Functional crosstalk between type I and II interferon through the regulated expression of STAT1.

Authors:  Daniel J Gough; Nicole L Messina; Linda Hii; Jodee A Gould; Kanaga Sabapathy; Ashley P S Robertson; Joseph A Trapani; David E Levy; Paul J Hertzog; Christopher J P Clarke; Ricky W Johnstone
Journal:  PLoS Biol       Date:  2010-04-27       Impact factor: 8.029

9.  BioGPS and MyGene.info: organizing online, gene-centric information.

Authors:  Chunlei Wu; Ian Macleod; Andrew I Su
Journal:  Nucleic Acids Res       Date:  2012-11-21       Impact factor: 16.971

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  125 in total

1.  IFN-β-specific signaling via a unique IFNAR1 interaction.

Authors:  Surinder Kaur; Leonidas C Platanias
Journal:  Nat Immunol       Date:  2013-09       Impact factor: 25.606

2.  Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ.

Authors:  Sebastian A Stifter; Antony Y Matthews; Niamh E Mangan; Ka Yee Fung; Alexander Drew; Michelle D Tate; Tatiana P Soares da Costa; Daniel Hampsey; Jemma Mayall; Phil M Hansbro; Albert Garcia Minambres; Sahar G Eid; Johnson Mak; Judy Scoble; George Lovrecz; Nicole A deWeerd; Paul J Hertzog
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

3.  Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection.

Authors:  Liang Cheng; Haisheng Yu; Guangming Li; Feng Li; Jianping Ma; Jingyun Li; Liqun Chi; Liguo Zhang; Lishan Su
Journal:  JCI Insight       Date:  2017-06-15

Review 4.  The molecular basis for differential type I interferon signaling.

Authors:  Gideon Schreiber
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

5.  Production of biologically active feline interferon beta in insect larvae using a recombinant baculovirus.

Authors:  Mariana Bernadett Arregui; Gregorio Juan Mc Callum; Ignacio Smith; Marcela Solange Villaverde; Federico Javier Wolman; Alexandra Marisa Targovnik; María Victoria Miranda
Journal:  3 Biotech       Date:  2018-07-27       Impact factor: 2.406

6.  A Brief Historical Perspective on the Pathological Consequences of Excessive Type I Interferon Exposure In vivo.

Authors:  Yanick J Crow; Pierre Lebon; Jean-Laurent Casanova; Ion Gresser
Journal:  J Clin Immunol       Date:  2018-09-05       Impact factor: 8.317

Review 7.  Spontaneous activation of RNA-sensing pathways in autoimmune disease.

Authors:  Steve P Crampton; Silvia Bolland
Journal:  Curr Opin Immunol       Date:  2013-12       Impact factor: 7.486

Review 8.  Decoding the complexity of type I interferon to treat persistent viral infections.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Trends Microbiol       Date:  2013-11-08       Impact factor: 17.079

Review 9.  Effects of type I interferons in malaria.

Authors:  Ismail Sebina; Ashraful Haque
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

Review 10.  Type I interferon in rheumatic diseases.

Authors:  Theresa L Wampler Muskardin; Timothy B Niewold
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.